Id	Study	Session	StudySession	SL	TL	Task	Text	Part	SGroup	TGroup	STid	SGid	STseg	TokS	LenS	TTid	TGid	TTseg	TokT	LenT	Ins	Del	Munit	InEff	FixS	TrtS	OrtS	OrtT	MU1rtS	MU1rtT	FFTimeS	FFDurS	FixT	TrtT	FFTimeT	FFDurT	CrossS	CrossT	Pause	Dur	End	Edit	Pause1	Time1	Ins1	Del1	Dur1	End1	Edit1	Pause2	Time2	Ins2	Del2	Dur2	End2	Edit2	PauseR	TimeR	InsR	DelR	DurR	EditR	Edit
1	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	How	Wie	1	1	1	1	3	1	1	1	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
2	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	does_work	funktioniert	2	2+4	1	2	8	2	2	1	1	9	26	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	11668	5538	17206	funktioniert_	11668	11668	13	0	2060	13728	funktioniert_[	0	0	0	0	0	0	---	0	0	0	0	0	---	funktioniert_
3	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	3	3	1	1	8	3	3	1	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
4	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	?	?	5	5	1	1	1	4	4	1	1	1	0	24	1	-1.0870	0	0	0	0	0	0	0	0	0	0	0	0	1	2	3478	21232	38438	[_zu_arbeiten	3478	17206	0	12	1997	19203	_zu_arbeiten]	0	0	0	0	0	0	---	0	0	0	0	0	---	[_zu_arbeiten
5	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	The	Der	6	6	2	1	3	5	5	2	1	3	14	14	1	29.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	19235	40170	78608	[aktive_[_evitka	19235	38438	7	7	25569	64007	aktive_[_evitka	0	0	0	0	0	0	---	0	0	0	0	0	---	[aktive_[_evitka
6	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	active_substance	Wirkstoff	7	7+8	2	2	15	6	6	2	1	16	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
7	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	in	in	9	9	2	1	2	7	7	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
8	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	10	10	2	1	8	8	8	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
9	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,	,	11	11	2	1	1	9	9	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
10	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	topotecan	Topotecan	12	12	2	1	9	10	10	2	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
11	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,	,	13	13	2	1	1	11	11	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
12	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	is	ist	14	14	2	1	2	12	12	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
13	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	an	ein	15	15	2	1	2	13	13	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
14	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	anticancer_medicine	Arzneimittel_gegen_Krebs	16	16+17	2	2	18	14	14+15+16	2	3	17	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
15	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	that	,_das	18	18	2	1	4	17	17+18	2	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
16	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	belongs	gehört	19	19	2	1	7	27	27	2	1	7	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	1872	2528	83008	[gehört	1872	80480	6	0	1482	81962	gehört	0	0	0	0	0	0	---	0	0	0	0	0	---	[gehört
17	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	to_the	zur	20	20+21	2	2	5	19	19	2	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-8	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
18	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	group	Gruppe	22	22	2	1	5	20	20	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
19	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	""""	""""	23	23	2	1	1	22	22	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
20	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	topoisomerase_inhibitors	Topoisomerase_-_Hemmer	24	24+25	2	2	23	23	23+24+25	2	3	22	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	2	14601	1872	80480	.	14601	78608	0	1	0	78608	.]	0	0	0	0	0	0	---	0	0	0	0	0	---	.
21	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	26	26	2	1	1	28	28	2	1	1	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	1046	47596	130604	.	1046	83008	1	0	0	83008	.[	0	0	0	0	0	0	---	0	0	0	0	0	---	.
22	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	It	Es	28	28	3	1	2	29	29	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
23	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	blocks	blockiert	29	29	3	1	6	30	30	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
24	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	an	ein	30	30	3	1	2	31	31	3	1	2	8	2	1	1.5714	0	0	0	0	0	0	0	0	0	0	0	0	1	1	35271	4010	499998	[das_]ein_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	35271	495988	4	1	656	das_]ein_	[das_]ein_
25	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	enzyme	Enzym	31	31	3	1	6	32	32	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
26	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	called	namens	32	32	3	1	6	33	33	3	1	6	14	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	3354	749	500747	namens_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	3354	499998	7	0	749	namens_	namens_
27	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	topoisomerase	Topoisomerase	33	33	3	1	13	34	34	3	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
28	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	I	I	34	34	3	1	1	35	35	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
29	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,	,	35	35	3	1	1	36	36	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
30	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	which	das	36	36	3	1	5	37	37	3	1	5	6	10	1	-5.6667	0	0	0	0	0	0	0	0	0	0	0	0	1	1	47596	2652	133256	[ni_ei]as_	47596	130604	3	5	2402	133006	ni_ei]as_	0	0	0	0	0	0	---	0	0	0	0	0	---	[ni_ei]as_
31	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	is	ist	37	37	3	1	2	44	44	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
32	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	involved	beteiligt	38	38	3	1	8	43	43	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
33	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	in	an	39	39	3	1	2	38	38	3	1	2	4	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	250	37376	170632	an	250	133256	2	0	93	133349	an[	0	0	0	0	0	0	---	0	0	0	0	0	---	an
34	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	der	40	40	3	1	3	39	39	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
35	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	division	Teilung	41	41	3	1	8	40	40	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
36	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	of	der	42	42	3	1	2	41	41	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
37	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	DNA	DNA	43	43	3	1	3	42	42	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
38	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	44	44	3	1	1	45	45	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
39	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	an	---	27	89	3	1	2	0	0	0	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	45	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
40	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	When	Wenn	45	45	4	1	4	46	46	4	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	0	-44	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
41	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	das	46	46	4	1	3	47	47	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
42	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	enzyme	Enzym	47	47	4	1	6	48	48	4	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
43	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	is	ist	48	48	4	1	2	50	50	4	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
44	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	blocked	blockiert	49	49	4	1	7	49	49	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
45	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,	,	50	50	4	1	1	51	51	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
46	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	die	51	51	4	1	3	53	53	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
47	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	DNA	DNA_-	52	52	4	1	3	54	54+55	4	2	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
48	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	strands	Stränge	53	53	4	1	7	56	56	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
49	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	break	brechen	54	54	4	1	5	52	52	4	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
50	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	55	55	4	1	1	57	57	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
51	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	This	Dies	56	56	5	1	4	58	58	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
52	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	prevents	verhindert	57	57	5	1	8	59	59	5	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
53	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	die	58	58	5	1	3	63	63	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
54	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	cancer_cells	Krebszellen	59	59+60	5	2	11	64	64	5	1	12	10	4	2	2.1429	0	0	0	0	0	0	0	0	0	0	0	0	1	2	40091	7677	196888	[an_der_Teilung]sich_[sich_	37283	170632	5	1	719	171351	an_der_Teilung]sich_	2808	190414	0	1	0	190414	sich_]	0	0	0	0	0	---	[an_der_Teilung]sich_[sich_
55	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	from_dividing	sich_teilen	61	61+62	5	2	12	62	62+65	5	2	12	22	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	2	5882	9499	190414	teilensich_	484	171835	6	0	748	172583	teilen[	5398	186780	5	0	826	187606	sich_[	0	0	0	0	0	---	teilensich_
56	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	and	und	63	63	5	1	3	67	67	5	1	3	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	5117	3276	180976	[sie_	5117	177700	0	1	0	177700	sie_]	0	0	0	0	0	0	---	0	0	0	0	0	---	[sie_
57	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	they	sie	64	64	5	1	4	70	70	5	1	4	8	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	6677	5757	197044	sie[_	203	181179	3	0	203	181382	sie	6474	196888	1	0	0	196888	_	0	0	0	0	0	---	sie[_
58	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	eventually	schließlich	65	65	5	1	10	68	68	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
59	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	die	sterben_ab	66	66	5	1	3	69	69+71	5	2	2	6	0	2	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	3432	14570	211411	[_ab	3276	180976	1	0	0	180976	_	156	197044	2	0	94	197138	ab[	0	0	0	0	0	---	[_ab
60	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	67	67	5	1	1	72	72	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
61	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	68	68	6	1	8	73	73	6	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
62	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	also	auch	69	69	6	1	4	75	75	6	1	4	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	2	1	359	15427	240848	[auh[h]ch_	359	225421	6	1	2012	227433	auh[h]ch_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[auh[h]ch_
63	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	affects	wirkt_auf	70	70	6	1	7	74	74+76	6	2	6	0	12	1	-1.1818	0	0	0	0	0	0	0	0	0	0	0	0	1	1	8596	4337	225421	[auch__hcis	8596	221084	0	6	3978	225062	auch__hcis]	0	0	0	0	0	0	---	0	0	0	0	0	---	[auch__hcis
64	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	non	Nicht	71	71	6	1	3	77	77	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
65	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	-	-	72	72	6	1	1	78	78	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
66	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	cancer_cells	Krebszellen	73	73+74	6	2	11	79	79	6	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
67	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,	,	75	75	6	1	1	80	80	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
68	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	which	was	76	76	6	1	5	81	81	6	1	5	8	2	1	1.5714	0	0	0	0	0	0	0	0	0	0	0	0	1	1	14273	9673	221084	[die_]was_	14273	211411	4	1	1077	212488	die_]was_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[die_]was_
69	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	causes	verursacht	77	77	6	1	6	83	83	6	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
70	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	side_effects	Nebenwirkungen	78	78+79	6	2	11	82	82	6	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
71	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	80	80	6	1	1	84	84	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
72	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	How	Wie	81	81	7	1	3	85	85	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
73	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	has	ist	82	82	7	1	3	86	86	7	1	3	8	2	1	1.5714	0	0	0	0	0	0	0	0	0	0	0	0	1	1	13415	4011	244859	[hat_]ist_	13415	240848	4	1	797	241645	hat_]ist_	0	0	0	0	0	0	---	0	0	0	0	0	---	[hat_]ist_
74	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	83	83	7	1	8	87	87	7	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
75	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	been	worden	84	84	7	1	4	89	89	7	1	4	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	171	33290	278320	worden	171	245030	6	0	702	245732	worden[	0	0	0	0	0	0	---	0	0	0	0	0	---	worden
76	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	studied	untersucht	85	85	7	1	7	88	88	7	1	7	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	3214	171	245030	_	3214	244859	1	0	0	244859	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
77	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	?	?	86	86	7	1	1	90	90	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
78	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	87	87	8	1	8	91	91	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
79	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	as	als	88	88	8	1	2	92	92	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
80	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	infusion	Infusion	90	90	8	1	8	93	93	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
81	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	has_been	wurde	91	91+92	8	2	7	94	94	8	1	8	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	2	32588	1608	279928	[hat_]wurde_	32588	278320	6	1	984	279304	hat_]wurde_	0	0	0	0	0	0	---	0	0	0	0	0	---	[hat_]wurde_
82	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	studied	untersucht	93	93	8	1	7	102	102	8	1	7	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	8	1	10233	22652	314685	[untersucht	10233	292033	10	0	1326	293359	untersucht	0	0	0	0	0	0	---	0	0	0	0	0	---	[untersucht
83	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	in	bei	94	94	8	1	2	95	95	8	1	2	6	4	1	3.6667	0	0	0	0	0	0	0	0	0	0	0	0	-7	1	624	12105	292033	bei[in	624	279928	3	2	1872	281800	bei[in]	0	0	0	0	0	0	---	0	0	0	0	0	---	bei[in
84	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	more	mehr	95	95	8	1	4	96	96	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
85	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	than	als	96	96	8	1	4	97	97	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
86	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	480	480	97	97	8	1	3	98	98	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
87	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	women	Frauen	98	98	8	1	5	99	99	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
88	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	with	mit	99	99	8	1	4	100	100	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
89	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	ovarian_cancer	Eierstockkrebs	100	100+101	8	2	13	101	101	8	1	14	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
90	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	who	,_bei_denen	102	102	8	1	3	103	103+104+105	8	3	1	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	21326	2043	316728	bei_denen_	21326	314685	10	0	1497	316182	bei_denen_[	0	0	0	0	0	0	---	0	0	0	0	0	---	bei_denen_
91	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	had	war	103	103	8	1	3	114	114	8	1	3	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	920	35442	362638	_	920	327196	0	1	0	327196	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
92	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	failed	gescheitert	104	104	8	1	6	113	113	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
93	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	one	eine	105	105	8	1	3	106	106	8	1	3	0	8	1	-1.2857	0	0	0	0	0	0	0	0	0	0	0	0	-7	1	546	4306	321034	[die_	546	316728	0	4	578	317306	die_	0	0	0	0	0	0	---	0	0	0	0	0	---	[die_
94	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	treatment	Behandlung	106	106	8	1	9	107	107	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
95	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	with	mit	107	107	8	1	4	108	108	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
96	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	platinum_-_containing	platinhaltigen	108	108+109+110	8	3	19	109	109	8	1	21	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
97	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	anticancer	gegen_Krebs	111	111	8	1	10	111	111+112	8	2	9	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	3728	3869	324903	,	3728	321034	0	1	0	321034	,	0	0	0	0	0	0	---	0	0	0	0	0	---	,
98	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	medicines	Arzneimitteln	112	112	8	1	9	110	110	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
99	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	113	113	8	1	1	115	115	8	1	1	0	34	1	-1.0606	0	0	0	0	0	0	0	0	0	0	0	0	5	1	3869	2293	327196	untersucht_worden	3869	324903	0	17	1373	326276	untersucht_worden	0	0	0	0	0	0	---	0	0	0	0	0	---	untersucht_worden
100	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Three	Drei	114	114	9	1	5	116	116	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
101	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	studies	Studien	115	115	9	1	7	117	117	9	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
102	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	were	waren	116	116	9	1	4	118	118	9	1	4	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	1	35442	12185	374823	seien_]waren_	35442	362638	6	1	1359	363997	seien_]waren_[	0	0	0	0	0	0	---	0	0	0	0	0	---	seien_]waren_
103	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	""""	""""	117	117	9	1	1	119	119	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
104	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	open	offen	118	118	9	1	4	120	120	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
105	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,	,	119	119	9	1	1	122	122	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
106	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	""""	""""	120	120	9	1	1	121	121	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
107	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	meaning	was_bedeutet	121	121	9	1	7	123	123+124	9	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
108	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	that	,_dass	122	122	9	1	4	125	125+126	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
109	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	das	123	123	9	1	3	127	127	9	1	3	6	20	1	-2.0769	0	0	0	0	0	0	0	0	0	0	0	0	1	1	10826	2559	377382	[nizideM_ei]as_	10826	374823	3	10	2309	377132	nizideM_ei]as_	0	0	0	0	0	0	---	0	0	0	0	0	---	[nizideM_ei]as_
110	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	medicine	Medikament	124	124	9	1	8	128	128	9	1	8	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	250	11856	389238	Medikament	250	377382	10	0	1528	378910	Medikament	0	0	0	0	0	0	---	0	0	0	0	0	---	Medikament
111	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	was	wurde	125	125	9	1	3	135	135	9	1	3	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	10328	7316	396554	wurde_	10328	389238	6	0	936	390174	wurde_[	0	0	0	0	0	0	---	0	0	0	0	0	---	wurde_
112	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	not	nicht	126	126	9	1	3	129	129	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-6	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
113	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	compared	verglichen	127	127	9	1	8	134	134	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
114	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	to	mit	128	128	9	1	2	130	130	9	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
115	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	any	einer	129	129	9	1	3	131	131	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
116	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	other	anderen	130	130	9	1	5	132	132	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
117	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	treatment	Behandlung	131	131	9	1	9	133	133	9	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
118	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	and	und	132	132	9	1	3	136	136	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
119	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	die	133	133	9	1	3	137	137	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
120	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	patients	Patienten	134	134	9	1	8	138	138	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
121	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	knew	wussten	135	135	9	1	4	139	139	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
122	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	that	,_dass	136	136	9	1	4	140	140+141	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
123	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	they	sie	137	137	9	1	4	142	142	9	1	4	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	6380	2402	398956	[erhielten_	6380	396554	0	1	0	396554	erhielten_]	0	0	0	0	0	0	---	0	0	0	0	0	---	[erhielten_
124	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	were_receiving	erhielten	138	138+139	9	2	13	144	144	9	1	14	18	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	172	16738	415866	erhielten	172	399128	9	0	1654	400782	erhielten[	0	0	0	0	0	0	---	0	0	0	0	0	---	erhielten
125	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	140	140	9	1	8	143	143	9	1	8	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	2402	172	399128	[_	2402	398956	1	0	0	398956	_	0	0	0	0	0	0	---	0	0	0	0	0	---	[_
126	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	141	141	9	1	1	145	145	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
127	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	The	Die	142	142	10	1	3	146	146	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
128	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	fourth	vierte	143	143	10	1	6	147	147	10	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
129	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	study	Studie	144	144	10	1	5	148	148	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
130	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	involved	schloss_ein	145	145	10	1	8	149	149+152	10	2	7	22	4	2	1.4211	0	0	0	0	0	0	0	0	0	0	0	0	4	1	15381	8362	424525	[umfasste_]schloss_ein[,	15084	415866	8	1	2013	417879	umfasste_]schloss_	297	420641	3	1	717	421358	ein[,	0	0	0	0	0	---	[umfasste_]schloss_ein[,
131	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	226	226	146	146	10	1	3	150	150	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
132	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	women	Frauen	147	147	10	1	5	151	151	10	1	5	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2465	297	420641	_	2465	420344	1	0	0	420344	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
133	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	,_and	und	148	148+149	10	2	4	153	153	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
134	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	compared	verglich	150	150	10	1	8	154	154	10	1	8	0	4	1	-1.6667	0	0	0	0	0	0	0	0	0	0	0	0	1	1	3167	32979	457504	ne	3167	424525	0	2	234	424759	ne	0	0	0	0	0	0	---	0	0	0	0	0	---	ne
135	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	Hycamtin	Hycamtin	151	151	10	1	8	155	155	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
136	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	with	mit	152	152	10	1	4	156	156	10	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
137	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	paclitaxel	Paclitaxel	153	153	10	1	10	157	157	10	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
138	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	(	(	154	154	10	1	1	158	158	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
139	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	another	ein_anderes	155	155	10	1	7	159	159+160	10	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
140	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	anticancer	gegen_Krebs	156	156	10	1	10	162	162+163	10	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
141	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	medicine	Arzneimittel	157	157	10	1	8	161	161	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
142	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	)	)	158	158	10	1	1	164	164	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
143	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	159	159	10	1	1	165	165	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
144	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	The	Der	160	160	11	1	3	166	166	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
145	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	main_measure	Hauptindikator	161	161+162	11	2	11	167	167	11	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
146	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	of	für	163	163	11	1	2	168	168	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
147	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	effectiveness	die_Wirksamkeit	164	164	11	1	13	169	169+170	11	2	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
148	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	was	war	165	165	11	1	3	171	171	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
149	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	the	die	166	166	11	1	3	172	172	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
150	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	number	Anzahl	167	167	11	1	6	173	173	11	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
151	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	of	der	168	168	11	1	2	174	174	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
152	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	patients	Patienten	169	169	11	1	8	175	175	11	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
153	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	whose	,_deren	170	170	11	1	5	176	176+177	11	2	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
154	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	tumours	Tumoren	171	171	11	1	7	178	178	11	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
155	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	responded	ansprachen	172	172	11	1	9	182	182	11	1	9	16	2	1	1.2667	0	0	0	0	0	0	0	0	0	0	0	0	4	1	32745	3213	460717	.]sprachen	32745	457504	8	1	2714	460218	.]sprachen	0	0	0	0	0	0	---	0	0	0	0	0	---	.]sprachen
156	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	to	auf	173	173	11	1	2	179	179	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
157	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	treatment	die_Behandlung	174	174	11	1	9	180	180+181	11	2	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
158	OCT13	P01_PF03	OCT13@P01_PF03	en	de	PF	03	P01	.	.	175	175	11	1	1	183	183	11	1	1	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	499	35271	495988	.	499	460717	1	0	0	460717	.[	0	0	0	0	0	0	---	0	0	0	0	0	---	.